Control cravings and reduce your appetite to achieve significant weight loss with the newest FDA-approved injectable prescription peptide for weight management
Semaglutide (brand names Wegovy and Ozempic) is a glucagon-like peptide (GLP-1) analog. GLP-1 is a hormone produced in the small intestine that stimulates insulin secretion and inhibits glucagon secretion, thereby lowering blood sugar. Studies show that Semaglutide reduces appetite, improves control of eating, and reduces food cravings in addition to improving glycemic control.
Semaglutide trial results showed overweight or obese adults receiving weekly Semaglutide had a weight loss of 14.9% at 68 weeks. In this same study, nearly 70% of participants were able to achieve a 10% weight loss threshold by taking Semaglutide and 32% of participants lost at least 20% of their initial weight!
Got a question? We’re here to help.
The common side effects of Semaglutide are:
Dr. Sosa will recommend OTC medications that may help alleviate these symptoms or prescribe medication for more significant symptoms.
ProLon® meals come in 5 small boxes (one for each day) that include plant-based energy bars, soups, a variety of snacks, drinks, and supplements, all studied and carefully designed to nourish your body and maintain healthy levels of metabolic markers, cellular rejuvenation, and healthy aging.
ProLon ingredients are primarily plant-based and do not contain additives, preservatives* or chemicals.